Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery
Conditions: Chronic Total Occlusion Interventions: Procedure: Percutaneous coronary intervention; Drug: Short dual Aspirin/Clopidogrel therapy; Other: Long dual Aspirin/Clopidogrel therapy; Other: Follow-up visit at 1 month; Other: Follow-up visit at 6 months; Other: Follow-up visit at 12 months Sponsors: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)
DiscussionWe hypothesize that pulse-dose methylprednisolone administrated in the pre-hospital setting decreases inflammation and thus reduces final infarct size in patients with STEMI treated with primary PCI.Trial registrationEU-CT number: 2022 –500762-10–00; Submitted May 5, 2022. ClinicalTrials.gov Identifier: NCT05462730; Submitted July 7, 2022, first posted July 18, 2022. (Source: Trials)
Source: Trials - December 15, 2023 Category: Research Source Type: clinical trials
Safety and Effectiveness of GENOSS DES in Patients With Multivessel Coronary Artery Disease
Conditions: Percutaneous Coronary Intervention; Multivessel Coronary Artery Disease Interventions: Device: Genoss DES Sponsors: Genoss Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
Conditions: Angina Pectoris; Coronary Artery Disease; Occlusion, Coronary Interventions: Procedure: Percutaneous coronary intervention. Sponsors: Pauls Stradins Clinical University Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy
Conditions: Left Ventricular Thrombus Interventions: Other: Primary percutaneous coronary intervention or thrombolytic therapy Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention
Conditions: In-stent Restenosis Interventions: Diagnostic Test: bone morphogenetic protein-2 (BMP-2) Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Precision PCI Registry
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Other: DNA sample collection Sponsors: University of Florida; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); University of Maryland, Baltimore Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
REgiStry-based Cardiovascular qUality improvEment Research
Conditions: Percutaneous Coronary Intervention; Heart Failure; Cardiometabolic Syndrome; Structural Heart Abnormality Interventions: Behavioral: Cardiac rehabilitation; Other: Active post-market surveillance of devices; Other: Multi-omics approach to precision medicine; Other: The prescription pattern analysis Sponsors: Peking University Third Hospital; Peking University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)
Conditions: High-risk Percutaneous Coronary Intervention; Heart Disease, Coronary Interventions: Device: VITALYST System Sponsors: Boston Scientific Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Complex CAD Treated With PCI With DES Implantation.
Conditions: Complex Coronary Artery Disease Interventions: Procedure: Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation Sponsors: Poznan University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb Ischemia
Conditions: Angioplasty; Infra Genicular; Critical Lower Limb Ischemia; Chronic Lower Limb Threatening Ischemia Interventions: Procedure: angioplasty Sponsors: Kafrelsheikh University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
Conditions: Diabetic Foot; Diabetes Mellitus; Peripheral Arterial Disease; Diabetic Neuropathies; Diabetic Retinopathy; Anemia; Ulcer Foot; Ulcer Ischemic; Diabetic Polyneuropathy Interventions: Procedure: percutaneous transluminal angioplasty Sponsors: Heinrich-Heine University, Duesseldorf; German Diabetes Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
A RanDomized Controlled Trial of the Drug Eluting TEmporary Spur StEnt System vs PERcutaneous Balloon Angioplasty for the TReatment of CriTical Limb Ischemia
Conditions: Critical Limb Ischemia Interventions: Device: Drug Eluting Temporary Spur Stent System; Device: Percutaneous Transluminal Balloon Angioplasty Sponsors: ReFlow Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
Conditions: Critical Limb Ischemia Interventions: Device: Drug Eluting Temporary Spur Stent System; Device: Percutaneous Transluminal Balloon Angioplasty Sponsors: ReFlow Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Correlation of Ultrasonographic Lesion Type Characterization With Angioplasty Outcomes in Failing Dialysis AVFs
Conditions: Dialysis Access Malfunction Interventions: Diagnostic Test: Ultrasound characterization of stenotic lesion type Sponsors: Attikon Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
